Skip to main content

DoW Joint Warfighter Medical, Military Medical Research and Development Award

Agency: Defense Health Agency Contracting Activity - DHACA

Assistance Listings
  • 12.420 -- Military Medical Research and Development

Closed opportunityLast Updated: Jun 17, 2026

Important dates

  • Closed: November 16, 2026

Award details

  • Expected project funding: $8,800,000
  • Expected awards: 4

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:HT942526JWMRPMMRDA
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
    • Grant
    • Other
    • Procurement contract
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Science technology and other research and development
  • Category Explanation:Not specified

History

  • Posted date: June 17, 2026
  • Archive date: December 16, 2026
  • Version: 1

View version history on Grants.gov

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.


Distinctive Features:


To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.


An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.

Eligibility

Miscellaneous

  • Unrestricted

Additional information on eligibility

Not specified

Documents

File nameDescriptionLast updated
HT942526JWMRPMMRDA_GG2.pdf
FY26 JWMRP MMRDA Broad Agency Announcement
Jun 24, 2026 08:13 PM UTC

Agency contact information

Email: help@eBRAP.org

eBRAP Help Desk

eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov